Ambryon Biosciences

AAV2H22 Serotype

AAV2 variant evolved for enhanced airway epithelial transduction from the apical surface, enabling efficient lung gene delivery.

TropismAirway epithelium (apical surface), lung

Characteristics

Peptide insertions conferring apical surface binding. Efficient transduction from airway lumen. Overcomes apical-basolateral polarity barrier. Enhanced respiratory tract tropism.

Applications

Cystic fibrosis gene therapy. Respiratory disease treatments. Alpha-1 antitrypsin deficiency. Lung-directed gene transfer.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Excoffon et al. (2009). Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci USA — Excoffon 2009 AAV2H22

Identifiers & revision